415 related articles for article (PubMed ID: 17962092)
1. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
Tse LF; Wong KC; Kumta SM; Huang L; Chow TC; Griffith JF
Bone; 2008 Jan; 42(1):68-73. PubMed ID: 17962092
[TBL] [Abstract][Full Text] [Related]
2. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
5. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of bisphosphonate to reduce local recurrence of sacral giant cell tumor after nerve-sparing surgery.
Xu W; Wang Y; Wang J; Yang X; Liu W; Zhou W; Liu T; Xiao J
J Neurosurg Spine; 2017 Jun; 26(6):716-721. PubMed ID: 28338455
[TBL] [Abstract][Full Text] [Related]
7. [Giant cell tumor of bone. An evaluation of 87 patients].
Tunn PU; Schlag PM
Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumor of extremities, surgical treatment and local adjuvants: which is the most effective?
Colangeli S; Del Chiaro A; Andreani L; D'Arienzo A; Parchi P; Capanna R
J Biol Regul Homeost Agents; 2020; 34(5 Suppl. 1):57-62. IORS Special Issue on Orthopedics. PubMed ID: 33739006
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
12. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
13. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
14. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of treatment of giant cell tumor of bone around the knee.
Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
[TBL] [Abstract][Full Text] [Related]
16. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
[TBL] [Abstract][Full Text] [Related]
17. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
19. Postoperative irrigation with bisphosphonates may reduce the recurrence of giant cell tumor of bone.
Yang T; Zheng XF; Lin X; Yin QS
Med Hypotheses; 2013 Nov; 81(5):851-2. PubMed ID: 23968573
[TBL] [Abstract][Full Text] [Related]
20. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
